Filing metadata

Accession number
0001104659-24-008797
Form type
Form 4
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Jan 31, 2024
Reporting period
Jan 30, 2024
Description
Insider transaction

Explore SEC Filings Hub